Cover Image
市場調查報告書

人工肺:醫療設備的開發平台分析

Artificial Lung - Medical Devices Pipeline Assessment, 2018

出版商 GlobalData 商品編碼 579814
出版日期 內容資訊 英文 37 Pages
訂單完成後即時交付
價格
Back to Top
人工肺:醫療設備的開發平台分析 Artificial Lung - Medical Devices Pipeline Assessment, 2018
出版日期: 2018年02月15日 內容資訊: 英文 37 Pages
簡介

本報告提供人工肺的開發中產品的相關調查,提供產品開發·臨床實驗的整體進展,及企業·各產品詳細趨勢(臨床實驗的進展,開始/結束時期,核准預測等),總括性彙整近幾年的開發趨勢等資訊。

第1章 目錄

第2章 簡介

  • 人工肺概要

第3章 開發中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各領域
  • 開發中產品:各核准機關
  • 開發中產品:各預定核准時期
  • 現在進行中的臨床實驗

第4章 人工肺-正在開發的開發中產品:各企業

  • 人工肺企業:各開發階段的開發中產品
  • 人工肺:各開發階段的開發中產品

第5章 人工肺:企業及產品概要

  • ALung Technologies Inc
    • 開發中產品及進行中的臨床實驗概要
  • Breethe, Inc.
  • Case Western Reserve University
  • Haemair Ltd
  • Lung Biotechnology PBC
  • McGowan Institute for Regenerative Medicine
  • MedArray Inc.
  • Michigan Critical Care Consultants, Inc.
  • Miromatrix Medical Inc
  • The Charles Stark Draper Laboratory Inc
  • University of California San Francisco
  • University of Pittsburgh
  • Xenios AG

第6章 人工肺:近幾年趨勢

第7章 附錄

  • 調查手法
  • 關於GlobalData
  • 聯絡處
  • 免責聲明

圖表清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0511EPD

GlobalData's Medical Devices sector report, "Artificial Lung - Medical Devices Pipeline Assessment, 2018" provides an overview of Artificial Lung currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Artificial Lung pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Artificial Lung under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Artificial Lung and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Artificial Lung under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 3
  • 1.2 List of Figures 4

2 Introduction 5

  • 2.1 Artificial Lung Overview 5

3 Products under Development 6

  • 3.1 Artificial Lung - Pipeline Products by Stage of Development 6
  • 3.2 Artificial Lung - Pipeline Products by Territory 7
  • 3.3 Artificial Lung - Pipeline Products by Regulatory Path 8
  • 3.4 Artificial Lung - Pipeline Products by Estimated Approval Date 9
  • 3.5 Artificial Lung - Ongoing Clinical Trials 10

4 Artificial Lung - Pipeline Products under Development by Companies 11

  • 4.1 Artificial Lung Companies - Pipeline Products by Stage of Development 11
  • 4.2 Artificial Lung - Pipeline Products by Stage of Development 12

5 Artificial Lung Companies and Product Overview 13

  • 5.1 ALung Technologies Inc Company Overview 13
    • 5.1.1 ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 13
  • 5.2 Breethe, Inc. Company Overview 17
    • 5.2.1 Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.3 Case Western Reserve University Company Overview 18
    • 5.3.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.4 Haemair Ltd Company Overview 19
    • 5.4.1 Haemair Ltd Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.5 Lung Biotechnology PBC Company Overview 20
    • 5.5.1 Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.6 McGowan Institute for Regenerative Medicine Company Overview 21
    • 5.6.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.7 MedArray Inc. Company Overview 23
    • 5.7.1 MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.8 Michigan Critical Care Consultants, Inc. Company Overview 24
    • 5.8.1 Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.9 Miromatrix Medical Inc Company Overview 25
    • 5.9.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.10 The Charles Stark Draper Laboratory Inc Company Overview 26
    • 5.10.1 The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.11 University of California San Francisco Company Overview 27
    • 5.11.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.12 University of Michigan Company Overview 28
    • 5.12.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.13 University of Pittsburgh Company Overview 29
    • 5.13.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.14 Xenios AG Company Overview 30
    • 5.14.1 Xenios AG Pipeline Products & Ongoing Clinical Trials Overview 30

6 Artificial Lung- Recent Developments 32

  • 6.1 Sep 27, 2017: ALung Receives IDE Approval to Conduct VENT-AVOID Trial of the Hemolung RAS for the US Market 32
  • 6.2 Apr 25, 2017: ALung Submits IDE Application to FDA Seeking Approval to Conduct Pivotal Study of the Hemolung RAS 33

7 Appendix 34

  • 7.1 Methodology 34
  • 7.2 About GlobalData 37
  • 7.3 Contact Us 37
  • 7.4 Disclaimer 37

List of Tables

1.1 List of Tables

  • Table 1: Artificial Lung - Pipeline Products by Stage of Development 6
  • Table 2: Artificial Lung - Pipeline Products by Territory 7
  • Table 3: Artificial Lung - Pipeline Products by Regulatory Path 8
  • Table 4: Artificial Lung - Pipeline Products by Estimated Approval Date 9
  • Table 5: Artificial Lung - Ongoing Clinical Trials 10
  • Table 6: Artificial Lung Companies - Pipeline Products by Stage of Development 11
  • Table 7: Artificial Lung - Pipeline Products by Stage of Development 12
  • Table 8: ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 13
  • Table 9: Hemolung RAS - Product Status 13
  • Table 10: Hemolung RAS - Product Description 13
  • Table 11: ALung Technologies Inc - Ongoing Clinical Trials Overview 14
  • Table 12: Hemolung RAS - A Prospective, Multi-center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support 15
  • Table 13: Hemolung RAS - Extra-corporeal CO2 Removal as an Adjunct to Non-Invasive Ventilation in Acute Severe Exacerbations of COPD 15
  • Table 14: Hemolung RAS - Physiological Study of Minimally Invasive Extracorporeal CO2 Removal in Exacerbations of COPD Requiring Invasive Mechanical Ventilation 15
  • Table 15: Hemolung RAS - Protective Ventilation with Veno-venous Lung Assist in Respiratory Failure 16
  • Table 16: Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 17: OXY-1 - Product Status 17
  • Table 18: OXY-1 - Product Description 17
  • Table 19: Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 20: Portable Artificial Lung - Product Status 18
  • Table 21: Portable Artificial Lung - Product Description 18
  • Table 22: Haemair Ltd Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 23: Portable Artificial Lung - Product Status 19
  • Table 24: Portable Artificial Lung - Product Description 19
  • Table 25: Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 26: Implantable Artificial Lung - Product Status 20
  • Table 27: Implantable Artificial Lung - Product Description 20
  • Table 28: McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 29: Biohybrid Artificial Lung - Product Status 21
  • Table 30: Biohybrid Artificial Lung - Product Description 21
  • Table 31: Chronic Artificial Lung - Product Status 22
  • Table 32: Chronic Artificial Lung - Product Description 22
  • Table 33: MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 34: Artificial Lung Fiber - Product Status 23
  • Table 35: Artificial Lung Fiber - Product Description 23
  • Table 36: Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 37: BioLung - Product Status 24
  • Table 38: BioLung - Product Description 24
  • Table 39: Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 40: Miromatrix Artificial Lung - Product Status 25
  • Table 41: Miromatrix Artificial Lung - Product Description 25
  • Table 42: The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 43: Silicone-Based Microfluidic Artificial Lung - Product Status 26
  • Table 44: Silicone-Based Microfluidic Artificial Lung - Product Description 26
  • Table 45: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 46: Neonatal ECMO Device - Product Status 27
  • Table 47: Neonatal ECMO Device - Product Description 27
  • Table 48: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 49: M-Lung - Product Status 28
  • Table 50: M-Lung - Product Description 28
  • Table 51: University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 52: Paracorporeal Ambulatory Assist Lung - Product Status 29
  • Table 53: Paracorporeal Ambulatory Assist Lung - Product Description 29
  • Table 54: Xenios AG Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 55: i-lung - Product Status 30
  • Table 56: i-lung - Product Description 30
  • Table 57: Xtralung - Product Status 31
  • Table 58: Xtralung - Product Description 31
  • Table 59: Glossary 36
Back to Top